Recurrent Implantable Cardioverter‐Defibrillator Replacement Is Associated with an Increasing Risk of Pocket‐Related Complications

Background:  Despite beneficial effects of implantable cardioverter‐defibrillator (ICD) therapy, limited service life results in replacement within the majority of patients. Data concerning the effect of replacement procedures on the occurrence of pocket‐related adverse events are scarce. In this study, the requirement for pocket‐related surgical re‐interventions following ICD treatment and the effect of device replacement were evaluated.

[1]  R. Hauser,et al.  The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. , 2005, Journal of the American College of Cardiology.

[2]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[3]  Dan M. Roden,et al.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .

[4]  M Gent,et al.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[5]  D. Hayes,et al.  Complication risk with pulse generator change: implications when reacting to a device advisory or recall. , 2006, Pacing and clinical electrophysiology : PACE.

[6]  R. Hauser,et al.  Learning from our mistakes? Testing new ICD technology. , 2008, The New England journal of medicine.

[7]  Jacques Victor,et al.  Risk Factors Related to Infections of Implanted Pacemakers and Cardioverter-Defibrillators: Results of a Large Prospective Study , 2007, Circulation.

[8]  Giuseppe Boriani,et al.  Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[9]  Jeroen J. Bax,et al.  Standardized screening and treatment of patients with life-threatening arrhythmias: the Leiden out-of-hospital cardiac arrest evaluation study. , 2004, Heart rhythm.

[10]  C. Cobbs,et al.  Infections in cardiac pacemakers. , 1988, Current clinical topics in infectious diseases.

[11]  M. Gold.  Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT) , 2010 .

[12]  Jeroen J. Bax,et al.  Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT). , 2009, European heart journal.

[13]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[14]  H Lelièvre,et al.  Role of the preaxillary flora in pacemaker infections: a prospective study. , 1998, Circulation.

[15]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[16]  J. Daubert,et al.  Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. , 2005, Journal of the American College of Cardiology.

[17]  P. Heidenreich,et al.  Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. , 2004, American heart journal.

[18]  R. Cappato,et al.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). , 2000, Circulation.

[19]  M. Petch,et al.  Late complications following permanent pacemaker implantation or elective unit replacement , 1998, Heart.

[20]  Claudia Stöllberger,et al.  Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.

[21]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[22]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.

[23]  Cobbs Cg,et al.  Infections in cardiac pacemakers. , 1988 .

[24]  E. Prystowsky,et al.  Complications Associated with Generator Replacement in Response to Device Advisories , 2008, Journal of cardiovascular electrophysiology.

[25]  A. Krahn,et al.  Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. , 2006, JAMA.

[26]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[27]  Jeroen J. Bax,et al.  Risk of Failure of Transvenous Implantable Cardioverter-Defibrillator Leads , 2008, Circulation. Arrhythmia and electrophysiology.

[28]  R. Cappato,et al.  A Randomized Comparison of Antiarrhythmic Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Cardiac Arrest: the Cardiac Arrest , 2000 .

[29]  David L Hayes,et al.  Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. , 2007, Journal of the American College of Cardiology.

[30]  A. Wilde,et al.  Clinical implementation of guidelines for cardioverter defibrillator implantation: lost in translation? , 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[31]  Riccardo Cappato,et al.  Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest The Cardiac Arrest Study Hamburg (CASH) , 2000 .

[32]  W. Maisel,et al.  Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. , 2006, JAMA.

[33]  J. Jukema,et al.  Risk factors and time delay associated with cardiac device infections: Leiden device registry , 2008, Heart.